Breaking News

NuvOx Completes Construction of Expanded Manufacturing Facility

Will manufacture its lead product, NanO2, for clinical trials and commercial supply after FDA approval.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NuvOx Pharma has completed construction and initiated operation of its GMP production facility for manufacturing its injectable pharmaceutical products at its Tucson, AZ facility. Construction of the GMP facility was financed by ImaRx Investments. The facility comprises an 1,800 square foot hard shell exterior space addition to the existing building located at 1635 East 18th Street. A 900 square foot ISO 5 cleanroom is housed within the exterior space.   “This same ISO 5 modular cleanroom, manuf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters